IRIS
FERRAU', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.792
NA - Nord America 4.536
AS - Asia 3.119
SA - Sud America 972
AF - Africa 87
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 14.512
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.419
RU - Federazione Russa 3.341
SG - Singapore 1.281
CN - Cina 920
BR - Brasile 828
IE - Irlanda 582
SE - Svezia 494
IT - Italia 401
HK - Hong Kong 320
DE - Germania 211
VN - Vietnam 205
PL - Polonia 174
FR - Francia 171
GB - Regno Unito 161
IN - India 87
FI - Finlandia 80
BD - Bangladesh 58
CA - Canada 47
AR - Argentina 45
MX - Messico 45
UA - Ucraina 39
TR - Turchia 36
ZA - Sudafrica 30
BE - Belgio 27
ID - Indonesia 26
JP - Giappone 23
EC - Ecuador 22
IQ - Iraq 22
UZ - Uzbekistan 21
CO - Colombia 20
PK - Pakistan 19
AT - Austria 18
MA - Marocco 18
NL - Olanda 18
VE - Venezuela 16
ES - Italia 14
PE - Perù 14
CZ - Repubblica Ceca 12
LT - Lituania 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
KE - Kenya 10
PH - Filippine 9
JO - Giordania 8
KG - Kirghizistan 8
MY - Malesia 8
TN - Tunisia 7
AL - Albania 6
IL - Israele 6
PY - Paraguay 6
CI - Costa d'Avorio 5
CR - Costa Rica 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
DZ - Algeria 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
JM - Giamaica 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
AM - Armenia 2
AU - Australia 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
PT - Portogallo 2
SR - Suriname 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
KW - Kuwait 1
Totale 14.502
Salva come PNG Salva come JPEG
Città #
Moscow 923
Ashburn 784
Singapore 679
Dublin 581
Chandler 482
Dallas 466
Beijing 337
San Jose 329
Hong Kong 317
Nyköping 300
The Dalles 171
Warsaw 163
Messina 153
Los Angeles 130
Jacksonville 123
Munich 109
Princeton 101
Medford 93
Lauterbourg 92
New York 84
Ann Arbor 74
Dearborn 73
Des Moines 70
Cambridge 64
São Paulo 61
Ho Chi Minh City 57
Lancaster 55
Council Bluffs 40
Shenyang 40
Hanoi 39
Buffalo 38
Redondo Beach 38
Brooklyn 35
Jinan 34
Orem 34
Tianjin 34
Frankfurt am Main 31
Santa Clara 30
Guangzhou 29
Boardman 28
Brussels 26
Hyderabad 26
Seattle 26
Wilmington 26
London 25
Rio de Janeiro 25
Helsinki 24
Houston 24
Turku 24
Belo Horizonte 23
Nanjing 22
Catania 21
Curitiba 20
Tashkent 20
Denver 19
Tokyo 19
Atlanta 18
Montreal 18
Johannesburg 17
San Mateo 17
Jakarta 15
Milan 15
Vienna 15
Chennai 14
Dong Ket 14
Pune 14
Stockholm 14
Zhengzhou 14
Brasília 13
Mexico City 13
Nanchang 13
Toronto 13
Ankara 12
Bremen 12
Düsseldorf 12
Hangzhou 12
Poplar 12
Shenzhen 12
Campinas 11
Chicago 11
Manchester 11
Nuremberg 11
Porto Alegre 11
Haikou 10
Hillsboro 10
Ningbo 10
San Francisco 10
Shanghai 10
Taizhou 10
Woodbridge 10
Baghdad 9
Boston 9
Da Nang 9
Goiânia 9
Lima 9
Nairobi 9
Ribeirão Preto 9
Rome 9
Amsterdam 8
Bishkek 8
Totale 8.213
Salva come PNG Salva come JPEG
Nome #
Aggressive pituitary adenomas: the dark side of the moon 268
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 247
Aggiornamento sulla chirurgia ipofisaria per via endoscopica: indicazioni, vantaggi e limiti 234
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 207
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 204
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 202
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 195
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 194
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 190
Effects of cyberknife radiotherapy treatment of pituitary adenomas 182
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 181
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 180
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 179
Global epidemiology of acromegaly: A systematic review and meta-analysis 179
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 178
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 177
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 176
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 175
Increased prevalence of acromegaly in a highly polluted area. 174
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 174
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 173
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 172
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 170
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 168
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 166
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 164
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 162
Course of pregnancies in women with Cushing's disease treated by gamma-knife 162
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 162
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 157
Multidisciplinary management of pituitary apoplexy 154
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 154
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex 153
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 152
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 150
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 150
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 150
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 149
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 147
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 145
Thyroid nodules in growth hormone replaced patients. 144
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 143
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 142
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 142
An unusual case of idiopathic hyperprolactinemia 139
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 138
Temozolomide-induced shrinkage of a pituitary carcinoma. 136
Absence of GNAS1 mutations in somatotropinomas from AIPmut positive patients: possible implications for phenotype. 136
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 136
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 135
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 134
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 134
Genetic and epigenetic modulation of AHR pathway in GH-secreting pituitary tumors and effects on acromegaly clinical phenotype 132
Epidemiology, course, and outcomes of Sars-CoV-2 infection in patients with acromegaly and Cushing’s disease: a monocentric experience in Southern Italy 131
Health-related quality of life in patients with Cushing's syndrome 131
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence 125
Cabergoline-related impulse control disorder in an adolescent with a giant prolactinoma 124
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 123
Endocrinologia & Malattie del Metabolismo 121
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 120
The man with acromegaly who inspired the Shrek animated project. 120
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 119
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis 116
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 116
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 113
Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome 108
Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma 107
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 107
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas 105
Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors 104
Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches 104
Are comorbidities of patients with adrenal incidentaloma tied to sex? 102
Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization. 102
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 101
X-linked acrogigantism: a new condition of growth hormone excess. 101
Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report 98
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 95
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 94
Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case 94
What we have to know about corticosteroids use during Sars-Cov-2 infection 93
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild? 92
GPR101 variants in acromegaly: results from a large series of patients. 92
The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease 92
Metabolic comorbidities in Cushing's syndrome 92
Italian Guidelines for the Management of Prolactinomas 91
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients 91
Emerging multitarget tyrosine kinase inhibitors in the treatment of neuroendocrine neoplasms 90
The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing's disease 87
Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion 85
Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas 85
Unique clinical picture in patients with X-linked acrogigantism 83
Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers 82
Metabolic syndrome in cushing's syndrome patients 82
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 82
Approccio al paziente con tumore ipofisario aggressivo 81
Systemic comorbidities induce early vascular alterations in patients with active acromegaly. 81
Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor 80
Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications 79
Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome 78
The Enhanced Proteasomal Degradation of AIP Mutant Proteins Is a Mechanism for AIP Deficiency in AIP mutation-Associated Pituitary Adenomas 78
Totale 13.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022656 1 69 12 30 18 10 27 23 10 95 119 242
2022/20231.710 162 177 77 132 112 157 36 91 683 14 43 26
2023/2024453 31 76 22 42 39 102 6 46 2 28 4 55
2024/20252.616 54 36 70 168 171 78 86 484 606 204 268 391
2025/20267.908 438 462 582 500 746 1.617 933 970 989 384 155 132
Totale 14.836